Ignite Creation Date:
2025-12-25 @ 3:39 AM
Ignite Modification Date:
2026-03-03 @ 8:12 AM
Study NCT ID:
NCT01291602
Status:
COMPLETED
Last Update Posted:
2017-09-01
First Post:
2011-02-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess the Safety, Tolerability and Pharmacokinetics of NXL104 Alone and in Combination With Ceftazidime Administered as Single and Repeated Intravenous Doses in Healthy Japanese Subjects
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-02
Start Date Type:
None
Primary Completion Date:
2011-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-04
Completion Date Type:
ACTUAL
First Submit Date:
2011-02-06
First Submit QC Date:
None
Study First Post Date:
2011-02-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-08-31
Last Update Post Date:
2017-09-01
Last Update Post Date Type:
ACTUAL